Manulife (Manufacturers Life Insurance)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-22,333
| Closed | -$1.07M | – | 3024 |
|
|
2020
Q1 | $1.07M | Buy |
22,333
+1,345
| +6% | +$64.6K | ﹤0.01% | 1493 |
|
|
2019
Q4 | $985K | Sell |
20,988
-96
| -0.5% | -$4.51K | ﹤0.01% | 1690 |
|
|
2019
Q3 | $506K | Buy |
21,084
+1,644
| +8% | +$39.5K | ﹤0.01% | 2007 |
|
|
2019
Q2 | $585K | Buy |
+19,440
| New | +$585K | ﹤0.01% | 1953 |
|
|
2018
Q3 | – | Sell |
-714
| Closed | -$7K | – | 4165 |
|
|
2018
Q2 | $7K | Hold |
714
| – | – | ﹤0.01% | 4021 |
|
|
2018
Q1 | $4K | Sell |
714
-2,399
| -77% | -$13.4K | ﹤0.01% | 4177 |
|
|
2017
Q4 | $26K | Sell |
3,113
-8,144
| -72% | -$68K | ﹤0.01% | 3730 |
|
|
2017
Q3 | $165K | Buy |
11,257
+397
| +4% | +$5.82K | ﹤0.01% | 3129 |
|
|
2017
Q2 | $204K | Buy |
10,860
+2,543
| +31% | +$47.8K | ﹤0.01% | 2991 |
|
|
2017
Q1 | $178K | Buy |
8,317
+6,097
| +275% | +$130K | ﹤0.01% | 2910 |
|
|
2016
Q4 | $34K | Buy |
+2,220
| New | +$34K | ﹤0.01% | 3507 |
|